Service de radio-oncologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


974 publications

... | 2020 | 2019 | 2018 | 2017 | 2016 | ...
2020
 
Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?
Biau J., Bourhis J., 2020/05. Current opinion in oncology, 32 (3) pp. 196-202. Peer-reviewed.
[DOI][Pmid][serval:BIB_0E170F81A2AC]
Exploration of clinical preferences in treatment planning of radiotherapy for prostate cancer using Pareto fronts and clinical grading analysis.
Kyroudi A., Petersson K., Ozsahin E., Bourhis J., Bochud F., Moeckli R., 2020/04. Physics and imaging in radiation oncology, 14 pp. 82-86. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D27CE2B93EFE]
Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm.
Jumeau R., Vincenti M.G., Pruvot E., Schwitter J., Vallet V., Zeverino M., Moeckli R., Bouchaab H., Bourhis J., Ozsahin M., 2020/03. Clinical and translational radiation oncology, 21 pp. 62-65. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F33C776D3308]
 
Radiotherapy in the treatment of extracranial hemangiopericytoma/solitary fibrous tumor: Study from the Rare Cancer Network
Krengli Marco, Cena Tiziana, Zilli Thomas, Jereczek-Fossa Barbara A., De Bari Berardino, Villa Freixa Salvador, Kaanders Johannes H.A.M., Torrente Sara, Pasquier David, Sole Claudio V. et al., 2020/03. Radiotherapy and Oncology, 144 pp. 114-120.
[DOI][Pmid][serval:BIB_B67366557871]
 
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines Committees.
Witjes J.A., Babjuk M., Bellmunt J., Bruins H.M., De Reijke T.M., De Santis M., Gillessen S., James N., Maclennan S., Palou J. et al., 2020/02. European urology, 77 (2) pp. 223-250. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F039FE6EE179]
 
Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J., Tao Y., Kortmann R.D., Zasadny X., Contreras-Martinez J., Ceruse P., Arias de la Vega F., Lalla R.V., Ozsahin E.M., Pajkos G. et al., 2020/02/01. International journal of radiation oncology, biology, physics, 106 (2) pp. 320-328. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_384C28D80AFF]
Extracellular Vesicles for the Treatment of Radiation-Induced Normal Tissue Toxicity in the Lung.
Montay-Gruel P., Zhu Y., Petit B., Leavitt R., Warn M., Giedzinski E., Ollivier J., Sinclair D.A., Vozenin M.C., Limoli C.L., 2020. Frontiers in oncology, 10 p. 602763. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_60652C973B9C]
Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity.
Szturz P., Van Laer C., Simon C., Van Gestel D., Bourhis J., Vermorken J.B., 2020. Frontiers in oncology, 10 p. 688. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FAFF518089A]
 
Le fardeau lié aux symptômes et les symptom clusters des patient·e·s atteint·e·s de cancer ORL et traité·e·s en radiothérapie. Onkologiepflege, 32-36, Nr. 2-2020 (2020).
Schuler Cosette, Hof Frank, Cardoso Rodrigo, Debarge Patricia, Manciana Stefania, Ninane Françoise, Bourhis Jean, Eicher Manuela, 2020/01..
[serval:BIB_0A795988D567]
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.
Pozzessere C., Bouchaab H., Jumeau R., Letovanec I., Daccord C., Bourhis J., Prior J.O., Peters S., Lazor R., Beigelman-Aubry C., 2020/01. ERJ open research, 6 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58E543FE8A79]
Stereotactic Gamma Knife Radiosurgery for Extracranial Arteriovenous Malformations.
Dedeciusova M., Tuleasca C., Hajdu S.D., Schiappacasse L., Patin D., Levivier M., 2020. Stereotactic and functional neurosurgery, 98 (6) pp. 424-431. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8AF7CB2FAA21]
Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions.
Jumeau R., Ozsahin M., Schwitter J., Elicin O., Reichlin T., Roten L., Andratschke N., Mayinger M., Saguner A.M., Steffel J. et al., 2020. Frontiers in cardiovascular medicine, 7 p. 108. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_01EC47B892C7]
 
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper.
Valentini V., Marijnen C., Beets G., Bujko K., De Bari B., Cervantes A., Chiloiro G., Coco C., Gambacorta M.A., Glynne-Jones R. et al., 2020/01. Radiotherapy and oncology, 142 pp. 6-16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F56E7E8B4F14]
 
The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F., Schiappacasse L., Levivier M., Tuleasca C., Cuendet M.A., Aedo-Lopez V., Gautron Moura B., Homicsko K., Bettini A., Berthod G. et al., 2020/01. Journal of neuro-oncology, 146 (1) pp. 181-193. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_18BD1C202E95]
2019
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
Pillonel V., Dunet V., Hottinger A.F., Berthod G., Schiappacasse L., Peters S., Michielin O., Aedo-Lopez V., 2019/12/02. Journal for immunotherapy of cancer, 7 (1) p. 336. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C48A9CE403D]
 
Recommended ESTRO Core Curriculum for Radiation Oncology/Radiotherapy 4th edition.
Benstead K., Lara P.C., Andreopoulos D., Bibault J.E., Dix A., Eller Y.G., Franco P., Guiliani M., Jaal J., Juretic A. et al., 2019/12. Radiotherapy and oncology, 141 pp. 1-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_591819B274BA]
 
Clinical evaluation of a novel optimization algorithm for cyberknife IRIS-based treatment plans
Zeverino Michele, Marguet Maud, Zulliger Cedric, Durham Andre, Jumeau Raphael, Herrera Fernanda, Schiappacasse Luis, Bourhis Jean, Bochud François, Moeckli Raphael, 2019/11/08. p. 1125 dans 23rd annual SASRO meeting, Strahlentherapie und Onkologie.
[serval:BIB_1FA4DE948ACB]
 
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
Horwich A., Babjuk M., Bellmunt J., Bruins H.M., Reijke T.M., Santis M., Gillessen S., James N., Maclennan S., Palou J. et al., 2019/11/01. Annals of oncology, 30 (11) pp. 1697-1727. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C58D4F25444]
 
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice.
Panje C., Zilli T., Pra A.D., Arnold W., Brouwer K., Garcia Schüler H.I., Gomez S., Herrera F., Khanfir K., Papachristofilou A. et al., 2019/10/16. Radiation oncology, 14 (1) p. 177. Peer-reviewed.
[DOI][Pmid][serval:BIB_3425523584B2]
 
Clinical translation of FLASH radiotherapy: Why and how?
Bourhis J., Montay-Gruel P., Gonçalves Jorge P., Bailat C., Petit B., Ollivier J., Jeanneret-Sozzi W., Ozsahin M., Bochud F., Moeckli R. et al., 2019/10. Radiotherapy and oncology, 139 pp. 11-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37467C7CDBF5]
 
Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate.
Jorge P.G., Jaccard M., Petersson K., Gondré M., Durán M.T., Desorgher L., Germond J.F., Liger P., Vozenin M.C., Bourhis J. et al., 2019/10. Radiotherapy and oncology, 139 pp. 34-39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9ACF7B46380F]
 
FLASH radiotherapy International Workshop.
Vozenin M.C., Baumann M., Coppes R.P., Bourhis J., 2019/10. Radiotherapy and oncology, 139 pp. 1-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A0818577F30]
 
High Z nanoparticles and radiotherapy: a critical view.
Vilotte F., Jumeau R., Bourhis J., 2019/10. The Lancet. Oncology, 20 (10) pp. e557. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8EF828242B6]
 
Outils pour la prédiction de la réponse tumorale et des tissus sains en oncologie radiothérapie [Predictive assays for responses of tumors and normal tissues in radiation oncology]
Riou O., Bourgier C., Brengues M., Bonnefoi N., Michaud H.A., Castan F., Gourgou S., Draghici R., Farcy-Jacquet M.P., Bons F. et al., 2019/10. Cancer radiotherapie, 23 (6-7) pp. 666-673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C28C3E2DC61D]
 
Personnalisation de la dose, du volume et du fractionnement de la radiothérapie du sein [Individual modification of the dose, volume and fractionation of breast radiotherapy]
Bourgier C., Lemanski C., Draghici R., Castan F., Fenoglietto P., Bons F., Farcy-Jacquet M.P., Brengues M., Gourgou S., Ozsahin M. et al., 2019/10. Cancer radiotherapie, 23 (6-7) pp. 778-783. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F0E75A4FBF5]
 
Treatment of a first patient with FLASH-radiotherapy.
Bourhis J., Sozzi W.J., Jorge P.G., Gaide O., Bailat C., Duclos F., Patin D., Ozsahin M., Bochud F., Germond J.F. et al., 2019/10. Radiotherapy and oncology, 139 pp. 18-22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_83AB60DD8B00]
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
Elicin Olgun, Ermiş Ekin, Oehler Christoph, Aebersold Daniel M., Caparrotti Francesca, Zimmermann Frank, Studer Gabriela, Henke Guido, Adam Lukas, Anschuetz Lukas et al., 2019/09/20. Frontiers in Oncology, 9.
[URN][DOI][WoS][serval:BIB_C091A29EFF41]
 
Current landscape of palliative radiotherapy for non-small-cell lung cancer.
Jumeau R., Vilotte F., Durham A.D., Ozsahin E.M., 2019/09. Translational lung cancer research, 8 (Suppl 2) pp. S192-S201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F60DE3B57B77]
 
Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
Riesterer O., Ciernik I.F., Stahel R.A., Xyrafas A., Aebersold D.M., Plasswilm L., Mahmut Ozsahin E., Zwahlen D.R., Nackaerts K., Zimmermann F. et al., 2019/09. Radiotherapy and oncology, 138 pp. 121-125. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22367B6D2F75]
 
Protonthérapie des carcinomes épidermoïdes des voies aérodigestives supérieures : de la physique à la clinique [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic]
Beddok A., Vela A., Calugaru V., Tessonnier T., Kubes J., Dutheil P., Gérard A., Vidal M., Goudjil F., Florescu C. et al., 2019/09. Cancer radiotherapie, 23 (5) pp. 439-448. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_08B31DBDDDBD]
 
Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
Ozsahin M., Slotman B.J., Bourhis J., 2019/09/01. International journal of radiation oncology, biology, physics, 105 (1) pp. 233-234. Peer-reviewed.
[DOI][Pmid][serval:BIB_330CC2516580]
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.
Lacombe J., Brengues M., Mangé A., Bourgier C., Gourgou S., Pèlegrin A., Ozsahin M., Solassol J., Azria D., 2019/08/09. Radiation oncology, 14 (1) p. 142. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5717C8853286]
 
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Burtness B., Haddad R., Dinis J., Trigo J., Yokota T., de Souza Viana L., Romanov I., Vermorken J., Bourhis J., Tahara M. et al., 2019/08/01. JAMA oncology, 5 (8) pp. 1170-1180. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF0BB6817B7E]
 
Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/08. Journal of cancer research and clinical oncology, 145 (8) p. 2167. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECD13E80CE3B]
Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation.
Zeverino M., Marguet M., Zulliger C., Durham A., Jumeau R., Herrera F.G., Schiappacasse L., Bourhis J., Bochud F.O., Moeckli R., 2019/08. Physica medica, 64 pp. 230-237. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B851A13DC5B2]
 
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
Dauzier E., Lacas B., Blanchard P., Le Q.T., Simon C., Wolf G., Janot F., Horiuchi M., Tobias J.S., Moon J. et al., 2019/08. Oral oncology, 95 pp. 106-114. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9729700C8902]
 
Letter by Jumeau et al Regarding Article, "Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia".
Jumeau R., Pruvot E., Bourhis J., 2019/07/02. Circulation, 140 (1) pp. e1-e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D5F93AFDBEC4]
 
Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken.
Vozenin M.C., Hendry J.H., Limoli C.L., 2019/07. Clinical oncology, 31 (7) pp. 407-415. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_72E25277DF5E]
Isodose 20 Gy found as a threshold dose for radiation recall dermatitis.
Scher N., Vozenin M.C., Bouchaab H., Ozsahin M., Bourhis J., 2019/07. Clinical and translational radiation oncology, 17 pp. 14-16. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FE74CAA7105A]
 
De la construction du bunker à la prise en charge du patient : contrôles qualité des techniques modernes de radiothérapie [From bunker construction to patient treatment: quality controls applied to modern radiotherapy techniques]
Klausner G., Blais E., Martin C., Biau J., Jumeau R., Canova C.H., Lyothier A., Slama Y., Jenny C., Chéa M. et al., 2019/06. Cancer radiotherapie, 23 (3) pp. 248-254. Peer-reviewed.
[DOI][Pmid][serval:BIB_389C4BF4DAD8]
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V., Pisano M., Lessert C., Petit B., Bouzourene K., Nahimana A., Vozenin M.C., Stergiopulos N., Swartz M.A., Mazzolai L., 2019/06. European journal of vascular and endovascular surgery, 57 (6) pp. 859-867. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3C19755AAAE9]
 
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.
Bourgier C., Auperin A., Rivera S., Boisselier P., Petit B., Lang P., Lassau N., Taourel P., Tetreau R., Azria D. et al., 2019/06/01. International journal of radiation oncology, biology, physics, 104 (2) pp. 365-373. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1F5238700811]
 
Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?
Haefliger S., Milowich D., Sciarra A., Trimeche M., Bouilly J., Kaiser J., Volpi S., Brouland J.P., Sempoux C., de Leval L., 2019/06. Annals of hematology, 98 (6) pp. 1513-1516. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D8635464310]
 
Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients.
Klausner G., Troussier I., Biau J., Jacob J., Schernberg A., Canova C.H., Simon J.M., Borius P.Y., Malouf G., Spano J.P. et al., 2019/06. Clinical genitourinary cancer, 17 (3) pp. 191-200. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E43E1B28D8A]
TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammation.
Petit V., Parcelier A., Mathé C., Barroca V., Torres C., Lewandowski D., Ferri F., Gallouët A.S., Dalloz M., Dinet O. et al., 2019/06. EBioMedicine, 44 pp. 60-70. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B0AB409E0E08]
 
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.
Montay-Gruel P., Acharya M.M., Petersson K., Alikhani L., Yakkala C., Allen B.D., Ollivier J., Petit B., Jorge P.G., Syage A.R. et al., 2019/05/28. Proceedings of the National Academy of Sciences of the United States of America, 116 (22) pp. 10943-10951. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60FFC8628F81]
 
Prise en charge des tachycardies ventriculaires réfractaires par radiothérapie stéréotaxique [Management of refractory ventricular tachycardia using stereotactic body radiotherapy]
Jumeau R., Bourhis J., Ozsahin M., Vallet V., Zeverino M., Moeckli R., Kinj R., Vozenin M.C., Schwitter J., Herrera-Siklody C. et al., 2019/05/22. Revue medicale suisse, 15 (652) pp. 1082-1086. Peer-reviewed.
[Pmid][serval:BIB_D535D630A0FE]
 
"Shared Decision Making Is the Gold Standard"!
Tsoutsou P.P., Belkacemi Y., 2019/05/01. International journal of radiation oncology, biology, physics, 104 (1) pp. 12-13. Peer-reviewed.
[DOI][Pmid][serval:BIB_E1FEA7743FE3]
 
In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data.
Schopfer M., Bochud F.O., Bourhis J., Moeckli R., 2019/05. Medical physics, 46 (5) pp. 1963-1971. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8381BE603F55]
 
Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?
Belkacemi Y., Majdoul S., Tsoutsou P.P., Abouegylah M., Kaidar-Person O., Meattini I., Poortmans PMP, Taghian A., 2019/05/01. International journal of radiation oncology, biology, physics, 104 (1) pp. 10-11. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82F32C7C404E]
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).
Curioni-Fontecedro A., Perentes J.Y., Gelpke H., Xyrafas A., Bouchaab H., Mach N., Matzinger O., Stojcheva N., Frueh M., Weder W. et al., 2019/05. British journal of cancer, 120 (10) pp. 968-974. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6DA91E6BDAAE]
 
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.
Biau J., Lapeyre M., Troussier I., Budach W., Giralt J., Grau C., Kazmierska J., Langendijk J.A., Ozsahin M., O'Sullivan B. et al., 2019/05. Radiotherapy and oncology, 134 pp. 1-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_854EAEC1624C]
Emerging patient-specific treatment modalities in head and neck cancer - a systematic review.
Elicin O., Cihoric N., Vlaskou Badra E., Ozsahin M., 2019/04. Expert opinion on investigational drugs, 28 (4) pp. 365-376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2709C035C3A9]
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/04. Journal of cancer research and clinical oncology, 145 (4) pp. 1075-1084. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_89462433D524]
Prostate cancer: On the road of progress.
Bolla M., Mirimanoff R.O., 2019/04. Asian journal of urology, 6 (2) pp. 123-124. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DE2C4D1E0E1A]
 
Lung Adenocarcinoma Metastasis to the Prostate: A Case Report.
Gilmour N., Mampuya W.A., Jumeau R., Dattner N., Ozsahin M., 2019/03. Practical radiation oncology, 9 (2) pp. 77-80. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF3E9AD2D040]
 
PET-based prognostic survival model after radiotherapy for head and neck cancer.
Castelli J., Depeursinge A., Devillers A., Campillo-Gimenez B., Dicente Y., Prior J.O., Chajon E., Jegoux F., Sire C., Acosta O. et al., 2019/03. European journal of nuclear medicine and molecular imaging, 46 (3) pp. 638-649. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D2D4701F91B6]
 
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019.
Belkacemi Y., Sio T.T., Colson-Durand L., Onal C., Villà S., Anacak Y., Krengli M., Thariat J., Ugurluer G., Miller R.C. et al., 2019/03. Critical reviews in oncology/hematology, 135 pp. 8-19. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB917F9DD87C]
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A5A6B3310C5]
 
Chimioradiothérapie des cancers de l’œsophage : revue critique de la littérature [Chemoradiation for oesophageal cancer: A critical review of the literature]
Blais E., Vendrely V., Sargos P., Créhange G., Huguet F., Maingon P., Simon J.M., Bourdais R., Ozsahin M., Bourhis J. et al., 2019/02. Cancer radiotherapie, 23 (1) pp. 62-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CB618748C66]
 
Experimentation to favor innovation: Promoting the success of Article 51 transformation projects.
Townsend A., de Trogoff H., Szwarcensztein K., participants of Giens XXXIV Round Table “Health and economy”, 2019/02. Therapie, 74 (1) pp. 51-57. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6F87F7E2F39]
 
Mise en place d’une politique de qualité et de sécurité lors de l’installation d’un nouvel équipement dans un service de radiothérapie [Quality and safety policy implementation for a new radiotherapy device]
Martin C., Jumeau R., Blais E., Canova C.H., Klausner G., Dumas R., Rouger A., Pariente F., Lyothier A., Slama Y. et al., 2019/02. Cancer radiotherapie, 23 (1) pp. 50-57. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3663CB8065E5]
 
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
Peters S., Dafni U., Boyer M., De Ruysscher D., Faivre-Finn C., Felip E., Garrido P., Girard N., Guckenberger M., Haanen J. et al., 2019/02/01. Annals of oncology, 30 (2) pp. 161-165. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_996A49F24542]
 
Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.
Biau J., Dunet V., Lapeyre M., Simon C., Ozsahin M., Grégoire V., Bourhis J., 2019/02. Radiotherapy and oncology, 131 pp. 192-201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F44E590836BE]
 
Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer.
Tsoutsou P.G., Vozenin M.C., 2019/01/01. JAMA oncology, 5 (1) pp. 111-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1030AE5EA05]
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.
Szturz P., Cristina V., Herrera Gómez R.G., Bourhis J., Simon C., Vermorken J.B., 2019. Frontiers in oncology, 9 p. 464. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_76EEE8FBE7D2]
 
Expanding the therapeutic index of radiation therapy by normal tissue protection.
Montay-Gruel P., Meziani L., Yakkala C., Vozenin M.C., 2019/01. The British journal of radiology, 92 (1093) p. 20180008. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33F51A1C2CCF]
Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly
Kinj Rémy, 2019. Radiation Oncology.
[URN][DOI][serval:BIB_CF99C8E63E37]
 
Gamma Knife radiosurgery for intravestibular and intracochlear schwannomas.
Tuleasca C., George M., Schiappacasse L., Patin D., Fenu J., Maire R., Levivier M., 2019/01. Acta neurochirurgica, 161 (1) pp. 63-67. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5B89860CC829]
 
GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event
Kinj Rémy, 2019. Breast Cancer Research and Treatment.
[DOI][serval:BIB_AE9E6C456F3B]
 
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01).
Früh M., Betticher D.C., Stupp R., Xyrafas A., Peters S., Ris H.B., Mirimanoff R.O., Ochsenbein A.F., Schmid R., Matzinger O. et al., 2019/01. Journal of thoracic oncology, 14 (1) pp. 115-123. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C7AD177ACA8A]
Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the "Best of" Trial.
Stelmes J.J., Gregoire V., Poorten V.V., Golusiñski W., Szewczyk M., Jones T., Ansarin M., Broglie M.A., Giger R., Klussmann J.P. et al., 2019. Frontiers in oncology, 9 p. 999. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8B74B0A94061]
 
The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.
Vozenin M.C., De Fornel P., Petersson K., Favaudon V., Jaccard M., Germond J.F., Petit B., Burki M., Ferrand G., Patin D. et al., 2019/01/01. Clinical cancer research, 25 (1) pp. 35-42. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD8C3C9FC9A2]
2018
 
Analysis of the treatment plan evaluation process in radiotherapy through eye tracking.
Kyroudi A., Petersson K., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 318-324. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_841A6F502AE7]
 
Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments.
Conrad M., Bolard G., Nowak M., De Bari B., Jeanneret-Sozzi W., Bourhis J., Germond J.F., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 276-285. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_892D1353C653]
 
Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability.
Tas B., Durmus I.F., Okumus A., Uzel O.E., Gokce M., Goksoy H.S., Ozsahin E.M., 2018/12. Radiotherapy and oncology, 129 (3) pp. 527-533. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_17DAF1080FC2]
 
X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice.
Montay-Gruel P., Bouchet A., Jaccard M., Patin D., Serduc R., Aim W., Petersson K., Petit B., Bailat C., Bourhis J. et al., 2018/12. Radiotherapy and oncology, 129 (3) pp. 582-588. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_402C7A2329DE]
 
Clinical Outcomes of Rectal Squamous Cell Carcinomas Treated with Chemoradiotherapy with or Without Surgery: A Rare Cancer Network Study.
De Bari B., Aloi D., Lemanski C., Hallemeier C.L., Touboul E., Qi S., Christie D., Vees H., Shulman K., Atasoy B.M. et al., 2018/11. International Journal of Radiation Oncology*Biology*Physics, 102 (3) pp. e3-e4.
[DOI][WoS][serval:BIB_968DF51DEB93]
 
Adaptive radiotherapy for head and neck cancer.
Castelli J., Simon A., Lafond C., Perichon N., Rigaud B., Chajon E., De Bari B., Ozsahin M., Bourhis J., de Crevoisier R., 2018/10. Acta oncologica, 57 (10) pp. 1284-1292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D054507CBEA]
 
Radiothérapie stéréotaxique vertébrale par CyberKnife® : résultats du Centre hospitalier universitaire vaudois
de Méric de Bellefon M., Vilotte F., Jumeau R., Saliou G., Bartolini B., Ruiz-Lopez N., Vallet V., Ozsahin E.M., Bourhis J., Schiappacasse L., 2018/10. Cancer/Radiothérapie, 22 (6-7) p. 727.
[DOI][serval:BIB_B5FC0DCFEC3E]
 
The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.
Daniel R.T., Tuleasca C., Rocca A., George M., Pralong E., Schiappacasse L., Zeverino M., Maire R., Messerer M., Levivier M., 2018/10. Journal of neurological surgery. Part B, Skull base, 79 (Suppl 4) pp. S362-S370. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AF0832F2B41]
Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review.
Feutren T., Herrera F.G., 2018/09. Prostate international, 6 (3) pp. 75-87. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF7FA8A5C5CA]
 
Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
Tao Y., Faivre L., Laprie A., Boisselier P., Ferron C., Jung G.M., Racadot S., Gery B., Even C., Breuskin I. et al., 2018/09. Radiotherapy and oncology, 128 (3) pp. 467-471. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_820BB085FC44]
 
Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.
Klausner G., Blais E., Jumeau R., Biau J., de Meric de Bellefon M., Ozsahin M., Zilli T., Miralbell R., Thariat J., Troussier I., 2018/08/20. Medical oncology, 35 (10) p. 134. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A69931C0EE76]
 
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.
Jumeau R., Ozsahin M., Schwitter J., Vallet V., Duclos F., Zeverino M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) pp. 189-191. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_157E3B9BB62F]
 
Response to Spartalis et al.
Jumeau R., Ozsahin M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) p. 388. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD1E10F6DA95]
 
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Geoffrois L., Martin L., De Raucourt D., Sun X.S., Tao Y., Maingon P., Buffet J., Pointreau Y., Sire C., Tuchais C. et al., 2018/07/17. Journal of clinical oncology, 36 (31 ) pp. 3077-3083. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97397E5FC84B]
A treatment planning comparison of contemporary photon-based radiation techniques for breast cancer
Zeverino Michele, Petersson Kristoffer, Kyroudi Archonteia, Jeanneret-Sozzi Wendy, Bourhis Jean, Bochud Francois, Moeckli Raphael, 2018/07. Physics and Imaging in Radiation Oncology, 7 pp. 32-38. Peer-reviewed.
[URN][DOI][serval:BIB_AD41E96A57F4]
 
In Regard to Pereira et al.
Azria D., Gourgou S., Brengues M., Bourgier C., Ozsahin M., 2018/06/01. International journal of radiation oncology, biology, physics, 101 (2) pp. 490-491. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_275888713DFE]
(F-18)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
Scher N., Castelli J., Depeursinge A., Bourhis J., Prior J.O., Herrera F.G., Ozsahin M., 2018/05. Cancer radiotherapie, 22 (3) pp. 229-235. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8D0209EBDD82]
 
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Sun X.S., Michel C., Babin E., De Raucourt D., Péchery A., Gherga E., Géry B., Florescu C., Bourhis J., Thariat J., 2018/04. Future oncology, 14 (9) pp. 877-889. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F163EA163C89]
 
EP-1225: Treatment outcomes of 382 patients treated with upfront exclusive radiosurgery for brain metastases
Schiappacasse L., Jumeau R., Tuleasca C., Vallet V., Biau J., Bouchaab H., Mederos N., Dunet V., Roux M., Meuli R. et al., 2018/04. pp. S679-S680 dans Radiotherapy and Oncology.
[DOI][serval:BIB_767EB652C0A2]
 
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.
De Bari B., Lestrade L., Franzetti-Pellanda A., Jumeau R., Biggiogero M., Kountouri M., Matzinger O., Miralbell R., Bourhis J., Ozsahin M. et al., 2018/04. Journal of cancer research and clinical oncology, 144 (4) pp. 781-789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_49A2277749ED]
 
PO-0722: Radiosurgery in association with immunotherapy for NSCLC brain metastases: feasibility and results
Schiappacasse L., Alshehri S., Jumeau R., Tuleasca C., Ahmad F., Mederos N., Bouchaab H., Levivier M., Bourhis J., 2018/04. Radiotherapy and Oncology, 127 pp. S369.
[DOI][serval:BIB_F0FB683AAA1A]
 
Short interactive workshops reduce variability in contouring treatment volumes for spine stereotactic body radiation therapy: Experience with the ESTRO FALCON programme and EduCase™ training tool.
De Bari B., Dahele M., Palmu M., Kaylor S., Schiappacasse L., Guckenberger M., ESTRO FALCON core, 2018/04. Radiotherapy and oncology, 127 (1) pp. 150-153. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4C9D0CA65C1F]
 
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., Erpolat P., Negretti L., Lassen-Ramshad Y., Onal C. et al., 2018/04. Radiotherapy and oncology, 127 (1) pp. 96-102. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_867DFDC10223]
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.
Bourgier C., Castan F., Riou O., Nguyen T.D., Peignaux K., Lemanski C., Lagrange J.L., Kirova Y., Lartigau E., Belkacemi Y. et al., 2018/03/20. Oncotarget, 9 (21) pp. 15757-15765. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_289EF15FCDC6]
 
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).
Frikha M., Auperin A., Tao Y., Elloumi F., Toumi N., Blanchard P., Lang P., Sun S., Racadot S., Thariat J. et al., 2018/03/01. Annals of oncology, 29 (3) pp. 731-736. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9BF3F128D15]
Comparison of 3DCRT and VMAT treatment in neoadjuvant oesophageal cancer.
Santa Cruz O (eds.), 2018/03., 92 Suppl 2.
[URN][DOI][Pmid][serval:BIB_46818D1BE984]
 
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages.
Meziani L., Mondini M., Petit B., Boissonnas A., Thomas de Montpreville V., Mercier O., Vozenin M.C., Deutsch E., 2018/03. The European respiratory journal, 51 (3) pp. NA. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_616092BA75B5]
 
Gamma Knife radiosurgery for glossopharyngeal neuralgia: A study of 21 patients with long-term follow-up.
Borius P.Y., Tuleasca C., Muraciole X., Negretti L., Schiappacasse L., Dorenlot A., Marguet M., Zeverino M., Donnet A., Levivier M. et al., 2018/03. Cephalalgia, 38 (3) pp. 543-550. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_66E5E92657CC]
 
Toxicité cardiaque de la radiothérapie : une réalité à prendre en compte [Cardiac toxicity induced by radiation therapy: a reality to consider]
Vozenin M.C., 2018/03. La Revue du praticien, 68 (3) pp. 330-331. Peer-reviewed.
[Pmid][serval:BIB_A89C5404F8EC]
 
High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use.
Jaccard M., Durán M.T., Petersson K., Germond J.F., Liger P., Vozenin M.C., Bourhis J., Bochud F., Bailat C., 2018/02. Medical physics, 45 (2) pp. 863-874. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AECCCBDB6D56]
 
A need for biology-driven personalized radiotherapy in breast cancer.
Tsoutsou P.G., Durham A.D., Vozenin M.C., 2018/01. Breast cancer research and treatment, 167 (2) pp. 603-604. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_26EEF7E656C6]
Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.
Boivin G., Kalambaden P., Faget J., Rusakiewicz S., Montay-Gruel P., Meylan E., Bourhis J., Lesec G., Vozenin M.C., 2018. Frontiers in oncology, 8 p. 256. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_64E7EAD7D9CF]
 
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V., Evans M., Le Q.T., Bourhis J., Budach V., Chen A., Eisbruch A., Feng M., Giralt J., Gupta T. et al., 2018/01. Radiotherapy and oncology, 126 (1) pp. 3-24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0A333FF2AFB]
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.
Tsoutsou P.G., Zaman K., Martin Lluesma S., Cagnon L., Kandalaft L., Vozenin M.C., 2018. Frontiers in oncology, 8 p. 609. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3F237867AE06]
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
Maria ATJ, Toupet K., Maumus M., Rozier P., Vozenin M.C., Le Quellec A., Jorgensen C., Noël D., Guilpain P., 2018. Frontiers in immunology, 9 p. 2571. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B10472CA6C87]
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
De Bari B., Breuneval T., Zeverino M., Godin S., Deantonio L., Geldhof C., Bourhis J., Schaefer N., Moeckli R., Prior J. et al., 2018. PloS one, 13 (10) pp. e0204013. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79CF07459545]
 
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Tao Y., Auperin A., Sire C., Martin L., Khoury C., Maingon P., Bardet E., Kaminsky M.C., Lapeyre M., Chatellier T. et al., 2018. Journal of clinical oncology, 36 ( 31) pp. 3084-3090. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_593234A96048]
 
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O., Tsoutsou P., Castella C., Khanfir K., Anchisi S., Bouayed S., Matzinger O., Ozsahin M., 2018. Oncology, 95 (2) pp. 61-68. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D70AE74A893E]
 
Re-irradiation of head and neck cancers: Target volumes, technical evolutions and prospects,Réirradiation des tumeurs de la tête et du cou: volumes cibles, évolutions techniques et perspectives
Kinj Rémy, 2018. Cancer/Radiotherapie.
[DOI][serval:BIB_C7A9977BE494]
 
Re-irradiation of head and neck cancers: Target volumes, technical evolutions and prospects,Réirradiation des tumeurs de la tête et du cou: volumes cibles, évolutions techniques et perspectives
Kinj Rémy, 2018. Cancer/Radiotherapie.
[DOI][serval:BIB_26A3F5D023DE]
 
Re-irradiation of head and neck cancers: Target volumes, technical evolutions and prospects,Réirradiation des tumeurs de la tête et du cou: volumes cibles, évolutions techniques et perspectives
Kinj Rémy, 2018. Cancer/Radiotherapie.
[DOI][serval:BIB_FF8E87A7C318]
Salvage-Radiotherapie bei makroskopischen Lokalrezidiven nach radikaler Prostatektomie : Nationale Umfrage zu Behandlungsmustern [Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice]
Dal Pra A., Panje C., Zilli T., Arnold W., Brouwer K., Garcia H., Glatzer M., Gomez S., Herrera F., Kaouthar K. et al., 2018/01. Strahlentherapie und Onkologie, 194 (1) pp. 9-16. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65346354F1F9]
Single fraction of accelerated partial breast irradiation in the elderly: Early clinical outcome
Kinj Rémy, 2018. Radiation Oncology.
[URN][DOI][serval:BIB_EA11FC80003C]
2017
Development and validation of a machine learning-based predictive model to improve the prediction of inguinal status of anal cancer patients: A preliminary report.
De Bari B., Vallati M., Gatta R., Lestrade L., Manfrida S., Carrie C., Valentini V., 2017/12/12. Oncotarget, 8 (65) pp. 108509-108521. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1E465AAD4A48]
Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.
Faget J., Groeneveld S., Boivin G., Sankar M., Zangger N., Garcia M., Guex N., Zlobec I., Steiner L., Piersigilli A. et al., 2017/12/12. Cell reports, 21 (11) pp. 3190-3204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1781FEB17DE0]
 
Letter: Cystic Vestibular Schwannomas Respond Best to Radiosurgery.
Tuleasca C., George M., Maire R., Schiappacasse L., Marguet M., Daniel R.T., Levivier M., 2017/12/01. Neurosurgery, 81 (6) pp. E80-E82. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4C546B47184D]
 
Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.
Pellanda A.F., De Bari B., Deniaud-Alexandre E., Krengli M., Van Houtte P., Richetti A., Villà S., Goldberg H., Szutowicz-Zielińska E., Bolla M. et al., 2017/12. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 29 (6) pp. 521-532. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E54B5099119E]
 
Radiosurgery in trochlear and abducens nerve schwannomas: case series and systematic review.
Peciu-Florianu I., Tuleasca C., Comps J.N., Schiappacasse L., Zeverino M., Daniel R.T., Levivier M., 2017/12. Acta neurochirurgica, 159 (12) pp. 2409-2418. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7253DD2A4B28]
 
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y., Auperin A., Sire C., Martin M., Saliou M.G., Bardet E., Sun X.S., Chatellier T., Morand C., Cornely A. et al., 2017/11/01. International journal of radiation oncology, biology, physics, 99 (3) pp. 590-595. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4C686C881374]
 
Contraintes de dose en radiothérapie conformationnelle fractionnée et en radiothérapie stéréotaxique dans les hippocampes, le tronc cérébral et l’encéphale : limites et perspectives [Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: Limits and perspectives]
Gérard M., Jumeau R., Pichon B., Biau J., Blais E., Horion J., Noël G., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 636-647. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1075D4FD22E]
 
Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie stéréotaxique : les poumons [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy]
Blais E., Pichon B., Mampuya A., Antoine M., Lagarde P., Kantor G., Breton-Callu C., Lefebvre C., Gerard M., Aamarcha A. et al., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 584-596. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C4518EC43DB]
 
Présentation de l’étude Gortec 2017-03 : radiothérapie en conditions stéréotaxiques postopératoire des cancers localisés de l’oropharynx et de la cavité buccale avec marges à risque (PHRC-K-16-164) [Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)]
Biau J., Miroir J., Millardet C., Saroul N., Pham-Dang N., Racadot S., Huguet F., Kwiatkowski F., Pereira B., Bourhis J. et al., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 527-532. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_418118EBB774]
 
Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body Radiation Therapy" [Critical Reviews in Oncology / Hematology 103C (2016) 49-61].
Berardino B., Laetitia P., Rosario M., Filippo A., Dorothea W.A., Markus S., Jean B., Mahmut O., 2017/09..
[DOI][Pmid][serval:BIB_E0597EFF4CFB]
 
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s.
Montay-Gruel P., Petersson K., Jaccard M., Boivin G., Germond J.F., Petit B., Doenlen R., Favaudon V., Bochud F., Bailat C. et al., 2017/09. Radiotherapy and oncology, 124 (3) pp. 365-369. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CC02F709CA04]
 
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
Lacas B., Bourhis J., Overgaard J., Zhang Q., Grégoire V., Nankivell M., Zackrisson B., Szutkowski Z., Suwiński R., Poulsen M. et al., 2017/09. The Lancet. Oncology, 18 (9) pp. 1221-1237. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D03980B3BE73]
 
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Blumenthal D.T., Gorlia T., Gilbert M.R., Kim M.M., Burt Nabors L., Mason W.P., Hegi M.E., Zhang P., Golfinopoulos V., Perry J.R. et al., 2017/08/01. Neuro-oncology, 19 (8) pp. 1119-1126. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DD040065DB11]
 
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Salas S., Resseguier N., Blay J.Y., Le Cesne A., Italiano A., Chevreau C., Rosset P., Isambert N., Soulie P., Cupissol D. et al., 2017/08/01. Annals of oncology, 28 (8) pp. 1979-1987. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_73A4901D503F]
 
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Tao Y., Aupérin A., Graff P., Lapeyre M., Grégoire V., Maingon P., Geoffrois L., Verrelle P., Calais G., Gery B. et al., 2017/08. Oral oncology, 71 pp. 61-66. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29331300F68D]
 
A clinical distance measure for evaluating treatment plan quality difference with Pareto fronts in radiotherapy
Petersson Kristoffer, Kyroudi Archonteia, Bourhis Jean, Ceberg Crister, Knöös Tommy, Bochud François, Moeckli Raphaël, 2017/07. Physics and Imaging in Radiation Oncology, 3 pp. 53-56. Peer-reviewed.
[DOI][serval:BIB_D0477065C76F]
 
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.
De Bari B., Stish B., Ball M.W., Habboush Y., Sargos P., Krengli M., Bossi A., Stabile A., Sole Pesutic C., Lestrade L. et al., 2017/07. The Prostate, 77 (10) pp. 1160-1166. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1069B1CCABF4]
 
Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.
Lestrade L., Zilli T., Kountouri M., Jumeau R., Matzinger O., Bourhis J., Miralbell R., Ozsahin M., De Bari B., 2017/07. Clinical oncology, 29 (7) pp. e105-e109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8EF282B39105]
Preserving normal facial nerve function and improving hearing outcome in large vestibular schwannomas with a combined approach: planned subtotal resection followed by gamma knife radiosurgery.
Daniel R.T., Tuleasca C., George M., Pralong E., Schiappacasse L., Zeverino M., Maire R., Levivier M., 2017/07. Acta neurochirurgica, 159 (7) pp. 1197-1211. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_579879995933]
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.
Herrmann E., Mertineit N., De Bari B., Hoeng L., Caparotti F., Leiser D., Jumeau R., Cihoric N., Jensen A.D., Aebersold D.M. et al., 2017/06/14. Radiation oncology, 12 (1) p. 97. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4A4DDC47242]
 
Acute clinical adverse radiation effects after Gamma Knife surgery for vestibular schwannomas
Tuleasca Constantin, George Mercy, Faouzi Mohamed, Schiappacasse Luis, Leroy Henri-Arthur, Zeverino Michele, Daniel Roy Thomas, Maire Raphael, Levivier Marc, 2017/06/01. pp. 39-40 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_AB2BAC7F3093]
 
Combined approach for large vestibular schwannomas: planned subtotal resection followed by Gamma Knife surgery in a series of 40 consecutive cases
Daniel Roy Thomas, Tuleasca Constantin, George Mercy, Schiappacasse Luis, Marguet Maude, Maire Raphael, Levivier Marc, 2017/06/01. p. 111 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_F92FAD9964E4]
 
First intention radiosurgery and combined approaches in trochlear and abducens nerve schwannomas
Comps Jean-Nicolas, Peciu-Florianu Iulia, Tuleasca Constantin, Schiappacasse Luis, Zeverino Michele, Daniel Roy-Thomas, Levivier Marc, 2017/06/01. pp. 29-30 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_D3F7BB87B664]
 
Gamma Knife radiosurgery for glossopharyngeal neuralgia: a bicentric experience of 21 patients
Borius Pierre-Yves, Tuleasca Constantin, Muraciol Xavier, Schiappacasse Luis, Dorenlot Antoine, Zeverino Michele, Donnet Anne, Levivier Marc, Regis Jean, 2017/06/01. pp. 35-36 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_4E9AF5B105C7]
 
Gamma Knife surgery for facial nerve schwannomas
Comps Jean-Nicolas, Tarabay Antonio, Tuleasca Constantin, George Mercy, Schiappacasse Luis, Marguet Maud, Maire Raphael, Levivier Marc, 2017/06/01. pp. 38-39 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_F4BB5096E1CC]
 
Jaw immobilization for Gamma Knife surgery in patients with mandibular lesions: A newly innovative approach
Tuleasca Constantin, Broome Martin, Mosimann Pascal, Schiappacasse Luis, Michele Zeverino, Dorenlot Antoine, Champoudry Jerome, Régis Jean, 2017/06/01. p. 120 dans Levivier Marc (eds.) 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_448B11B44B5A]
 
Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?
Castelli J., Depeursinge A., de Bari B., Devillers A., de Crevoisier R., Bourhis J., Prior J.O., 2017/06. Clinical nuclear medicine, 42 (6) pp. e281-e285. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E7E6BC7209D]
 
Planned subtotal resection followed by GKR for complex skull base meningiomas: Lausanne experience
Giammattei Lorenzo, Tuleasca Constantin, Schiappacasse Luis, Marguet Maud, Borruat François-Xavier, Levivier Marc, Daniel Roy Thomas, 2017/06/01. pp. 17-18 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_FD483A9B40F1]
 
Stereotactic radiosurgery in association with immune checkpoint therapy for brain metastases of non-small cell lung cancer: feasibility and results
Alshehri Samirah, Jumeau Raphael, Tuleasca Constantin, Ahmad Farah, Mederos Nuria, Bouchaab Hasna, Cherif Mohamed, Levivier Marc, Bourhis Jean, Schiappacasse Luis, 2017/06/01. pp. 59-60 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_ECE7E098C5A7]
 
Trigeminal neuralgia secondary to intracranial lesions: a prospective series of 20 consecutive cases
Schweyzer Lucia, Tuleasca Constantin, Schiappacasse Luis, Zeverino Michele, Levivier Marc, 2017/06/01. pp. 137-138 dans 13th International Stereotactic Radiosurgery Society Congress (ISRS 2017), J Radiosurg SBRT.
[serval:BIB_89A256EAFA3E]
 
Cancer du sein de stade précoce : la désescalade thérapeutique sélective [Selective therapeutic de-escalation in early stage breast cancer]
Liapi A., Sarivalasis A., Jeanneret Sozzi W., Lelièvre L., Zaman K., 2017/05/17. Revue medicale suisse, 13 (563) pp. 1035-1038. Peer-reviewed.
[Pmid][serval:BIB_7A29F888A008]
 
Cancers de la sphère ORL : l’immunothérapie donne de la voix ! [Head and neck cancer : promising results of immunotherapy]
Sivade A., Bensaid D., Monnier Y., Shabafrouz K., Bouchaab H., Cristina V., 2017/05/17. Revue medicale suisse, 13 (563) pp. 1029-1031. Peer-reviewed.
[Pmid][serval:BIB_FFCBF161F44F]
 
18-FDG PET-CT parameters to predict survival and recurrence in cervical cancer patients treated with chemo-radiotherapy
Scher Nathaniel, Castelli Joel, Depeursinge Adrien, Breuneval T., Bourhis J ., Prior John O., Ozsahin Esat, Herrera Fernanda, 2017/05., European Society for Radiotherapy and Oncology dans European Society for Radiotherapy and Oncology.
[serval:BIB_BDB032481E57]
 
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s
Montay-Gruel Pierre, Petersson Kristoffer, Jaccard Maud, Boivin Gaël, Germond Jean-François, Petit Benoit, Doenlen Raphaël, Favaudon Vincent, Bochud François, Bailat Claude et al., 2017/05. Radiotherapy and Oncology.
[DOI][Pmid][serval:BIB_07BFF093E10E]
 
Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
Morisod B., Venara-Vulpe I.I., Alzuphar S., Monnier Y., Bongiovanni M., Hagmann P., Bouchaab H., Bourhis J., Simon C., 2017/05. Head & neck, 39 (5) pp. 965-973. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_923FC2198B46]
 
OC-0039: Unique sparing of spatial memory in mice after whole brain irradiation with dose rates above 100Gy/s
Petersson K., Montay-Gruel P., Jaccard M., Boivin G., Germond J., Petit B., Bochud F., Bailat C., Bourhis J., Vozenin M., 2017/05. Radiotherapy and Oncology, 123 pp. S15-S16.
[DOI][serval:BIB_C20629DF4305]
 
TAT-RasGAP317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.
Tsoutsou P., Annibaldi A., Viertl D., Ollivier J., Buchegger F., Vozenin M.C., Bourhis J., Widmann C., Matzinger O., 2017/05. Radiation research, 187 (5) pp. 562-569. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13F935643BF3]
 
A PET-based nomogram for oropharyngeal cancers.
Castelli J., Depeursinge A., Ndoh V., Prior J.O., Ozsahin M., Devillers A., Bouchaab H., Chajon E., de Crevoisier R., Scher N. et al., 2017/04. European journal of cancer, 75 pp. 222-230. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF335D446D50]
 
Commissioning of the Leksell Gamma Knife(®) Icon™.
Zeverino M., Jaccard M., Patin D., Ryckx N., Marguet M., Tuleasca C., Schiappacasse L., Bourhis J., Levivier M., Bochud F.O. et al., 2017/04. Medical physics, 44 (2) pp. 355-363. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B05F3B565B79]
 
High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films.
Jaccard M., Petersson K., Buchillier T., Germond J.F., Durán M.T., Vozenin M.C., Bourhis J., Bochud F.O., Bailat C., 2017/04. Medical physics, 44 (2) pp. 725-735. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9458B8F6BDDF]
 
Les promesses du haut débit de dose en radiothérapie [Hopes of high dose-rate radiotherapy]
Fouillade C., Favaudon V., Vozenin M.C., Romeo P.H., Bourhis J., Verrelle P., Devauchelle P., Patriarca A., Heinrich S., Mazal A. et al., 2017/04. Bulletin du cancer, 104 (4) pp. 380-384. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1BB4EDB587CB]
 
Linear-Endobronchial Ultrasound-Guided Insertion of a Fiducial Marker: A New Tool for Tracking Central Lesions.
Casutt A., Koutsokera A., Peguret N., Lovis A., 2017/04. Journal of bronchology & interventional pulmonology, 24 (2) pp. 166-169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_877DEFE7A875]
 
Prolonged Apnea Supported by High-Frequency Noninvasive Ventilation: A Pilot Study.
Ogna A., Bernasconi M., Belmondo B., Long O., Simons J., Peguret N., Heinzer R., Nicod L.P., Bourhis J., Lovis A., 2017/04/01. American journal of respiratory and critical care medicine, 195 (7) pp. 958-960. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_405CF44041D8]
 
Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer.
Jumeau R., Peguret N., de Bari B., Moeckli R., Soares-Rodrigues J.L., Durham A.D., Hojnowski S., Bourhis J., Ozsahin M., Beigelman-Aubry C., 2017/04. Journal of medical imaging and radiation oncology, 61 (2) pp. 252-257. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD6976D82574]
 
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.
Rotolo F., Pignon J.P., Bourhis J., Marguet S., Leclercq J., Tong Ng W., Ma J., Chan A.T., Huang P.Y., Zhu G. et al., 2017/04. Journal of the National Cancer Institute, 109 (4) pp. 1-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01129E815553]
 
First intention radiosurgery and combined approach in trochlear and abducens nerve
Peciu-Florianu I., Tuleasca C., Schiappacasse L., Severino M., Daniel R.T., Levivier M., 2017/03. pp. 66-67 dans Société de neurochirurgie de langue française , Neurochirurgie.
[DOI][serval:BIB_F07391192D91]
 
High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.
Petersson K., Jaccard M., Germond J.F., Buchillier T., Bochud F., Bourhis J., Vozenin M.C., Bailat C., 2017/03. Medical physics, 44 (3) pp. 1157-1167. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_18FD4B43C453]
Implementation of TomoEDGE in the independent dose calculator CheckTomo.
Schopfer M., Thomas S.J., Tudor G.S., Bourhis J., Bochud F., Moeckli R., 2017/03. Journal of applied clinical medical physics, 18 (2) pp. 92-99. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_77F489044345]
 
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.
Alongi F., Arcangeli S., De Bari B., Giaj-Levra N., Fiorentino A., Mazzola R., Trovò M., 2017/03. Critical reviews in oncology/hematology, 112 pp. 67-71. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87F4CD45B199]
 
The latest prospects of investigational drugs for head and neck cancer.
Elicin O., Ozsahin M., 2017/03. Expert opinion on investigational drugs, 26 (3) pp. 265-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38B2CC14D9E6]
 
Abstract P6-09-52: Prognostic factors in breast cancer (BC) associated with the development of brain metastases (BM): A retrospective study of 726 pts
Santa Cruz O, Tsoutsou P, Anchisi S, Khanfir K, Negretti L, Girardet C, Ozsoy O, Ozsahin M, 2017/02/15., San Antonio Breast Cancer Symposium pp. P6-09-52-P6-09-52 dans Cancer Research, American Association for Cancer Research (AACR).
[DOI][WoS][serval:BIB_14F6EEDDA1DE]
 
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?
De Bari B., Durham A., Bourhis J., Ozsahin M., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 573-574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF41C886AEDA]
 
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
Ribassin-Majed L., Marguet S., Lee AWM, Ng W.T., Ma J., Chan ATC, Huang P.Y., Zhu G., Chua DTT, Chen Y. et al., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 498-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47F24284E77D]
 
Current Trends in Thoracic Radio-oncology
Matzinger O, Peters S, 2017/02/01. Schweizer Krebsbulletin, Nr 2/2017.
[serval:BIB_35E08FB97BA2]
 
How could breast cancer molecular features contribute to locoregional treatment decision making?
Tsoutsou P.G., Vozenin M.C., Durham A.D., Bourhis J., 2017/02. Critical reviews in oncology/hematology, 110 pp. 43-48. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3744B53511C]
 
T lymphocytes to predict radiation-induced late effects in normal tissues.
Brengues M., Lapierre A., Bourgier C., Pèlegrin A., Özsahin M., Azria D., 2017/02. Expert review of molecular diagnostics, 17 (2) pp. 119-127. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F1C94CD71E9]
 
Chest-MRI under pulsatile flow ventilation: A new promising technique.
Beigelman-Aubry C., Peguret N., Stuber M., Delacoste J., Belmondo B., Lovis A., Simons J., Long O., Grant K., Berchier G. et al., 2017. PloS one, 12 (6) pp. e0178807. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61A86B64EF6E]
Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage.
Bayart E., Pouzoulet F., Calmels L., Dadoun J., Allot F., Plagnard J., Ravanat J.L., Bridier A., Denozière M., Bourhis J. et al., 2017. PloS one, 12 (1) pp. e0168395. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE2E9E7C7B50]
 
Establishing a formal sarcoma center for children and adults at the Lausanne University Hospital
Bosisio Francesca, Matter Maurice, Fortin Aurélie, CHUV Multidisciplinary Sarcoma Team, 2017. Swiss Knife 3 pp. 16-19. Peer-reviewed.
[serval:BIB_B13928EA1DBE]
 
High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber
Petersson Kristoffer, Jaccard Maud, Germond Jean-François, Buchillier Thierry, Bochud François, Bourhis Jean, Vozenin Marie-Catherine, Bailat Claude, 2017/01. Medical Physics.
[DOI][serval:BIB_3A94298611E1]
 
Linear-Endobronchial Ultrasound-guided Insertion of a Fiducial Marker: A New Tool for Tracking Central Lesions.
Casutt A., Koutsokera A., Peguret N., Lovis A., 2017. Journal of Bronchology and Interventional Pulmonology, 24 (2) pp. 166-69. Peer-reviewed.
[DOI][Pmid][serval:BIB_89BB3C86C1BF]
 
Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy
Kinj Rémy, 2017. Clinical Colorectal Cancer.
[DOI][serval:BIB_265E1A26511F]
 
Radiotherapy combination opportunities leveraging immunity for the next oncology practice.
Herrera F.G., Bourhis J., Coukos G., 2017/01. CA: a cancer journal for clinicians, 67 (1) pp. 65-85. Peer-reviewed.
[DOI][Pmid][serval:BIB_558CD2425591]
2016
 
Centre des sarcomes : un nouvel outil pour améliorer la prise en charge du patient et soutenir la recherche [Sarcoma centres : a necessary tool in the management of patients and for research.]
Cherix S., Vauclair F., Morattel B., Vautrin M., Matter M., Montemurro M., Digklia A., Letovanec I., Omoumi P., Saucy F. et al., 2016/12/14. Revue medicale suisse, 12 (543) pp. 2172-2176. Peer-reviewed.
[Pmid][serval:BIB_B4139C33D819]
 
Acute clinical adverse radiation effects after Gamma Knife surgery for vestibular schwannomas.
Tuleasca C., George M., Faouzi M., Schiappacasse L., Leroy H.A., Zeverino M., Daniel R.T., Maire R., Levivier M., 2016/12. Journal of neurosurgery, 125 (Suppl 1) pp. 73-82. Peer-reviewed.
[Pmid][serval:BIB_F4C847D86F1F]
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Castelli J., De Bari B., Depeursinge A., Simon A., Devillers A., Roman Jimenez G., Prior J., Ozsahin M., de Crevoisier R., Bourhis J., 2016/12. Critical reviews in oncology/hematology, 108 pp. 40-51. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C4724EBB7453]
Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma.
Jumeau R., Bahig H., Filion É., Campeau M.P., Lambert L., Roberge D., Gorgos A.B., Vu T., 2016/11/29. Cureus, 8 (11) pp. e901.
[URN][DOI][Pmid][serval:BIB_46E3FF2DA70A]
 
High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study.
Pichon B., Campion L., Delpon G., Thillays F., Carrie C., Cellier P., Pommier P., Laude C., Mervoyer A., Hamidou H. et al., 2016/11/15. International journal of radiation oncology, biology, physics, 96 (4) pp. 840-847.
[DOI][Pmid][serval:BIB_CC104D8A51CB]
Difference in performance between 3D and 4D CBCT for lung imaging: a dose and image quality analysis.
Thengumpallil S., Smith K., Monnin P., Bourhis J., Bochud F., Moeckli R., 2016/11/08. Journal of applied clinical medical physics, 17 (6) p. 6459. Peer-reviewed.
[URN][Pmid][serval:BIB_19ADA467B85A]
 
Extreme hypofractionation for early prostate cancer: Biology meets technology.
De Bari B., Arcangeli S., Ciardo D., Mazzola R., Alongi F., Russi E.G., Santoni R., Magrini S.M., Jereczek-Fossa B.A., on the behalf of the Italian Association of Radiation Oncology (AIRO), 2016/11. Cancer treatment reviews, 50 pp. 48-60. Peer-reviewed.
[DOI][Pmid][serval:BIB_60D37AE2B2B5]
 
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Cacicedo J., Navarro A., Del Hoyo O., Gomez-Iturriaga A., Alongi F., Medina J.A., Elicin O., Skanjeti A., Giammarile F., Bilbao P. et al., 2016/11. The British journal of radiology, 89 (1067) p. 20160217. Peer-reviewed.
[DOI][Pmid][serval:BIB_9F2C7865C7CF]
 
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
De Bari B., Jumeau R., Deantonio L., Adib S., Godin S., Zeverino M., Moeckli R., Bourhis J., Prior J.O., Ozsahin M., 2016/10/13. Tumori, 102 (5) pp. e21-e24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1A1BF451D4B5]
 
Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial.
Früh M., Ris H.B., Xyrafas A., Peters S., Mirimanoff R.O., Gautschi O., Pless M., Stupp R., 2016/10. Annals of oncology, 27 (10) pp. 1971-1973. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B17A250595A6]
 
Radiation Therapy for Extracranial Hemangiopericytoma/Solitary Fibrous Tumor: A Study From the Rare Cancer Network
Krengli M., De Bari B., Villa S., Kaanders J.H.A.M., Torrente S., Pasquier D., Thariat J.O., Myroslav L., Sole C.V., Dincbas H.F. et al., 2016/10. pp. E707 dans Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics, American Society for Radiation Oncology.
[DOI][WoS][serval:BIB_C9F1201D735A]
 
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?
Jereczek-Fossa B.A., Ciardo D., Petralia G., Bellomi M., De Bari B., De Cobelli O., Orecchia R., 2016/09. Critical reviews in oncology/hematology, 105 pp. 100-111. Peer-reviewed.
[DOI][Pmid][serval:BIB_00F99FD62C6A]
 
Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma.
van der Steen-Banasik E., Christiaens M., Shash E., Coens C., Casado A., Herrera F.G., Ottevanger P.B., European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC-GCG), 2016/09. European journal of cancer, 65 pp. 172-181. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2787CB42ADE8]
 
Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study.
Altinok A.Y., Yildirim S., Altug T., Sut N., Ober A., Ozsahin E.M., Azria D., Bese N.S., 2016/08. Breast (Edinburgh, Scotland), 28 pp. 174-177. Peer-reviewed.
[DOI][Pmid][serval:BIB_F28B3D254082]
 
Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization.
Kyroudi A., Petersson K., Ghandour S., Pachoud M., Matzinger O., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2016/08. Radiotherapy and oncology, 120 (2) pp. 346-348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE39A063851D]
 
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.
De Bari B., Porta L., Mazzola R., Alongi F., Wagner A.D., Schäfer M., Bourhis J., Ozsahin M., 2016/07. Critical reviews in oncology/hematology, 103 pp. 49-61. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE057E94F72E]
Traitement curatif du cancer de l'oesophage: consensus multidisciplinaire multicentrique [Curative treatment for esophageal cancer: results of a multidisciplinary consensus]
Allemann P., Mantziari S., Wagner D., Digklia A., Ozsahin E., De Bari B., Dorta G., Godat S., Montserrat F., Sempoux C. et al., 2016/06/15. Revue medicale suisse, 12 (523) pp. 1165-1169. Peer-reviewed.
[URN][Pmid][serval:BIB_58E6531A0AFA]
 
Current Role of Dacomitinib in Head and Neck Cancer.
Elicin O., Ozsahin M., 2016/06. Expert opinion on investigational drugs, 25 (6) pp. 735-742. Peer-reviewed.
[DOI][Pmid][serval:BIB_252EC8A01882]
 
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B., Jumeau R., Bouchaab H., Vallet V., Matzinger O., Troussier I., Mirimanoff R.O., Wagner A.D., Hanhloser D., Bourhis J. et al., 2016/06. Acta oncologica (Stockholm, Sweden), 55 (6) pp. 767-773. Peer-reviewed.
[DOI][Pmid][serval:BIB_BBF294B0BDC2]
 
Impact of respiratory-correlated CT sorting algorithms on the choice of margin definition for free-breathing lung radiotherapy treatments
Thengumpallil Sheeba, Germond Jean-François, Bourhis Jean, Bochud François, Moeckli Raphaël, 2016/06. Radiotherapy and Oncology, 119 (3) pp. 438-443.
[DOI][serval:BIB_50BB7EE573F2]
 
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.
De Bari B., Deantonio L., Bourhis J., Prior J.O., Ozsahin M., 2016/06. Critical reviews in oncology/hematology, 102 pp. 111-117. Peer-reviewed.
[DOI][Pmid][serval:BIB_58638AE058BE]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University